Olivier Vandenberg Selected Research

Olivier Vandenberg Research Topics

5	Infections 12/2022 - 01/2004
5	COVID-19 11/2021 - 01/2020
1	Coma (Comas) 01/2021
1	Hyperammonemia 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 01/2020
1	Clonorchiasis 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Pneumonia (Pneumonitis) 04/2017
1	Pulmonary Embolism 04/2017
1	Virus Diseases (Viral Diseases) 07/2014
1	Epstein-Barr Virus Infections 06/2013
1	Dientamoebiasis 01/2007
1	Campylobacter Infections (Campylobacter Infection) 05/2006

3	Immunoglobulin G (IgG)IBA 11/2021 - 06/2013
2	Azithromycin (Zithromax)FDA LinkGeneric 12/2022 - 01/2021
2	AntibodiesIBA 11/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2018
2	AntigensIBA 01/2020 - 01/2020
2	Immunoglobulin M (IgM)IBA 01/2020 - 06/2013
2	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2012 - 01/2007
2	Erythromycin (Erycette)FDA LinkGeneric 05/2006 - 01/2004
1	Nucleocapsid ProteinsIBA 11/2021
1	Neutralizing AntibodiesIBA 11/2021
1	AmmoniaIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	NucleoproteinsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	favipiravirIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Gold Colloid (Colloidal Gold)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	4-hexyloxyaniline (HOA)IBA 01/2020
1	Vancomycin FDA LinkGeneric 04/2017
1	Amoxicillin (Wymox)FDA LinkGeneric 04/2017
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 04/2017
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2004

1	Critical Care (Surgical Intensive Care) 01/2021
1	Therapeutics 01/2021
1	Lung Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 07/2014